Target intelligence / Profile preview

Clostridium septicum alpha-toxin (ATX)

Target
ATX
Molecular classification
Bacterial exotoxin, Pore-forming toxin, Aerolysin family
01

Overview

Clostridium septicum alpha-toxin is a potent, pore-forming exotoxin and the primary virulence factor of the gram-positive bacterium Clostridium septicum (Kennedy et al., 2005, PubMed: 15805227). It is synthesized as an inactive 51 kDa protoxin that requires proteolytic cleavage of a C-terminal peptide, typically by host cell furin, to become active (Gordon et al., 1997, PubMed: 9351814). Once activated, the toxin binds with high affinity to glycosylphosphatidylinositol (GPI)-anchored proteins, such as CD59, on the surface of host cells, where it oligomerizes to form heptameric pores (Knapp et al., 2010, PubMed: 20083661). These pores disrupt the plasma membrane's integrity, leading to rapid efflux of potassium ions, influx of calcium, and eventual cell death through necrosis or apoptosis. Clinically, this toxin is the driving force behind spontaneous gas gangrene (myonecrosis), a condition characterized by rapid tissue destruction and high mortality, often occurring in patients with underlying immunosuppression or gastrointestinal malignancies (Stevens & Bryant, 2017, StatPearls). Therapeutic strategies focus on neutralizing the toxin using antitoxins and suppressing its production through protein-synthesis-inhibiting antibiotics like clindamycin (PubMed: 28603331).

Other names
Alpha-toxinC. septicum lethal toxinPore-forming toxin alphaClostridium septicum lethal alpha-toxin
02

Mechanism of action

Neutralization of the toxin by specific antibodies to prevent binding to host cell receptors and subsequent pore formation (StatPearls, 2023).

03

Biological functions

CytolysisPore formationMembrane permeabilizationCell deathIon transport disruption
04

Disease associations

Gas gangreneMyonecrosisNeutropenic enterocolitisSepsisClostridial myonecrosis
05

Safety considerations

Fulminant progression of myonecrosisSystemic inflammatory response syndrome (SIRS)High case-fatality rateAssociation with occult malignancy (colorectal cancer)
06

Interacting drugs

Clostridium septicum antitoxin

3 more in the full profile.

07

Biomarkers

Serum alpha-toxin levels (ELISA)Clostridium septicum DNA (PCR)Creatine kinase (CK) elevationLactate dehydrogenase (LDH) elevation

Beyond the preview

Go deeper on Clostridium septicum alpha-toxin (ATX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridium septicum alpha-toxin (ATX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call